The results showed that in patients with NPM1mut/FLT3-ITDneg/low AML, unfavorable cytogenetics were linked to a lower 5-year OS rate (52.4%, 44.8%, and 19.5% for normal, aberrant intermediate, and adverse karyotypes, respectively). Here, FLT3 is linked to acute myeloid leukemia.